Long-term adefovir therapy may induce Fanconi syndrome: A report of four cases

  • Authors:
    • Fan Pan
    • Yingchao Wang
    • Xin Zhang
    • Qingfeng Lin
    • Xiaolong Liu
    • Yi Jiang
    • Chen Pan
  • View Affiliations

  • Published online on: May 22, 2017     https://doi.org/10.3892/etm.2017.4483
  • Pages: 424-430
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Fanconi syndrome is a rare disease characterized by dysfunction of the proximal renal tubules as a result of various pathogenic events. Drug‑induced Fanconi syndrome may be neglected or misdiagnosed, which increases the level of suffering. The aim of the present study was to conduct an investigation into the effects of adefovir (ADV)-induced Fanconi syndrome. Four typical cases of Fanconi syndrome caused by long‑term ADV therapy (2‑9 years) were diagnosed at our hospital. A complete medical and therapy history was collected from all four patients prior to a physical examination. Laboratory and diagnostic examinations were also conducted. Following this, the patients were diagnosed and a treatment regimen was decided upon. Outcomes of the treatment regimen were observed. Common manifestations of all the four patients were: Renal tubular reabsorption dysfunction; imbalanced electrolyte acid‑base ratio; elevated cystatin C levels; severe hypophosphatemia and diffused systemic pain; osteoporosis; and difficultly walking. When ADV was replaced with supportive treatment, all the four patients exhibited symptom relief. These findings indicate that long‑term ADV therapy may induce Fanconi syndrome. For patients with a history of such therapy, the possibility of Fanconi syndrome should be assessed and monitored closely for indicators, including altered glomerular and renal tubular function. Once diagnosed, the agent should be immediately discontinued and prompt symptomatic treatment should be administered.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 14 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Pan F, Wang Y, Zhang X, Lin Q, Liu X, Jiang Y and Pan C: Long-term adefovir therapy may induce Fanconi syndrome: A report of four cases. Exp Ther Med 14: 424-430, 2017
APA
Pan, F., Wang, Y., Zhang, X., Lin, Q., Liu, X., Jiang, Y., & Pan, C. (2017). Long-term adefovir therapy may induce Fanconi syndrome: A report of four cases. Experimental and Therapeutic Medicine, 14, 424-430. https://doi.org/10.3892/etm.2017.4483
MLA
Pan, F., Wang, Y., Zhang, X., Lin, Q., Liu, X., Jiang, Y., Pan, C."Long-term adefovir therapy may induce Fanconi syndrome: A report of four cases". Experimental and Therapeutic Medicine 14.1 (2017): 424-430.
Chicago
Pan, F., Wang, Y., Zhang, X., Lin, Q., Liu, X., Jiang, Y., Pan, C."Long-term adefovir therapy may induce Fanconi syndrome: A report of four cases". Experimental and Therapeutic Medicine 14, no. 1 (2017): 424-430. https://doi.org/10.3892/etm.2017.4483